跳至主要内容
临床试验/EUCTR2018-000597-29-FR
EUCTR2018-000597-29-FR招募中1 期

Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis - NPT-MAR

Centre Hospitalier Régional Metz-Thionville0 个研究点目标入组 85 人开始时间: 2019年3月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patient over 18 years old,
  • Patient with persistent mild to severe or moderate to severe intermittent rhinitis according to ARIA criteria, suspicion of allergic rhinitis to dust mites, and a positive skin test for mites and / or a positive mite specific IgE assay
  • Patient having signed a free and informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 70
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • Pregnant or breastfeeding women
  • Patients under guardianship or curatorship
  • Patients under legal protection
  • Patients not affiliated to a social security scheme
  • Contraindications to performing a RNPT
  • o Active ENT or respiratory infections.
  • o Allergy in acute phase.
  • o History of anaphylaxis due to the allergen involved.
  • o Unstabilized asthma and other obstructive pathologies.
  • o Severe general illnesses in evolution.
  • o Hypersensitivity to one of the components of the product
  • o Simultaneous treatment with beta-blockers or angiotensin-converting enzyme (ACE) inhibitors,
  • o Presence of an excessive degree of sensitization (e.g. history, excessive skin reactions),
  • Contraindications to immunotherapy:
  • o Asthma (uncontrolled)
  • o Active autoimmune diseases
  • o Malignant tumors
  • o Pregnancy (initiation of venereal disease)

研究者

发起方
Centre Hospitalier Régional Metz-Thionville

相似试验